SAGE May 2024 27.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:52PM EDT. Market open.
| Previous Close | 0.1300 |
| Open | 0.1500 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 27.50 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.1300 - 0.1500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 287 |
Insider MonkeySage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Simply Wall St.Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
Investors in Sage Therapeutics, Inc. ( NASDAQ:SAGE ) had a good week, as its shares rose 2.7% to close at US$13.69...
ZacksSage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
© 2024 Yahoo. All rights reserved.